Answer
Farydak (panobinostat), combined with bortezomib and dexamethasone, treats adults with relapsed and/or refractory multiple myeloma who have received at least two prior regimens including bortezomib and an immunomodulatory agent.
Sources for this answer
- Farydak 10mg hard capsulespharmaand GmbH · emc · SmPC §4.1 Therapeutic Indications · Version 3Document updated
Sources checked